Zimmer Biomet Holdings Inc

Latest Results (17.12.2024):

Net Sales Growth

In the third quarter of 2024, Zimmer Biomet Holdings Inc. reported net sales of $1.824 billion, marking a 4.0% increase compared to the same period in the previous year. On a constant currency basis, the sales growth was slightly higher at 4.1%. This growth reflects the company's ability to maintain a steady increase in sales despite various challenges.

Earnings Per Share

Zimmer Biomet Holdings Inc. achieved diluted earnings per share of $1.23 for the third quarter of 2024. When adjusted for certain items, the diluted earnings per share increased to $1.74. This adjustment highlights the company's efforts to present a clearer picture of its financial performance by excluding specific non-recurring items.

Net Earnings

The company's net earnings for the third quarter of 2024 were reported at $249.1 million. On an adjusted basis, which accounts for certain non-recurring items, net earnings were $353.2 million. This adjustment provides a more accurate representation of the company's ongoing profitability.

Financial Guidance Update

Zimmer Biomet Holdings Inc. updated its financial guidance for the full year 2024, reducing and narrowing its projected ranges for revenue growth and adjusted diluted EPS. The company now expects a reported revenue change of 3.5% to 4.0% and adjusted diluted EPS between $7.95 and $8.05. This update reflects the company's cautious outlook amid current market conditions.

Geographic Sales Performance

In the third quarter of 2024, Zimmer Biomet Holdings Inc. experienced varied sales performance across different regions. In the United States, net sales reached $1,052.3 million, while international sales were $771.9 million. The growth rates for these regions were 2.0% and 6.9%, respectively, indicating stronger performance in international markets.